Two Sigma Investments’s Atea Pharmaceuticals AVIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.32M Buy
366,612
+114,863
+46% +$414K ﹤0.01% 2042
2025
Q1
$753K Sell
251,749
-34,172
-12% -$102K ﹤0.01% 2273
2024
Q4
$958K Sell
285,921
-55,840
-16% -$187K ﹤0.01% 2148
2024
Q3
$1.14M Sell
341,761
-33,314
-9% -$112K ﹤0.01% 1988
2024
Q2
$1.24M Buy
375,075
+2,825
+0.8% +$9.35K ﹤0.01% 1804
2024
Q1
$1.5M Buy
372,250
+210,341
+130% +$850K ﹤0.01% 1637
2023
Q4
$494K Buy
161,909
+107,813
+199% +$329K ﹤0.01% 2388
2023
Q3
$162K Sell
54,096
-121,084
-69% -$363K ﹤0.01% 2600
2023
Q2
$655K Buy
+175,180
New +$655K ﹤0.01% 2123
2022
Q4
Sell
-98,482
Closed -$560K 2739
2022
Q3
$560K Sell
98,482
-12,035
-11% -$68.4K ﹤0.01% 1677
2022
Q2
$785K Sell
110,517
-491,485
-82% -$3.49M ﹤0.01% 1592
2022
Q1
$4.35M Sell
602,002
-187,663
-24% -$1.35M 0.01% 957
2021
Q4
$7.06M Buy
+789,665
New +$7.06M 0.02% 781